Christian Ehmann
Stock Analyst at Berenberg Bank
(0.47)
# 3,971
Out of 4,349 analysts
182
Total ratings
41.3%
Success rate
-4.1%
Average return
Main Sectors:
Stocks Rated by Christian Ehmann
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: EVT Evotec SE | Maintained: Buy | €9.70 | $5.11 | +89.82% | 38 | Apr 13, 2026 | |
| ETR: GXI Gerresheimer AG | Maintained: Hold | €30.00 → €20.00 | $27.90 | -28.32% | 13 | Feb 16, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Buy | €22.00 | $16.90 | +30.18% | 4 | Feb 12, 2026 | |
| ETR: DMP Dermapharm Holding SE | Maintained: Hold | €41.00 | $49.10 | -16.50% | 4 | Aug 26, 2025 | |
| ETR: FYB Formycon AG | Maintained: Buy | €40.00 | $21.30 | +87.79% | 14 | Aug 13, 2025 | |
| ETR: DRW3 Drägerwerk AG & Co. KGaA | Maintained: Buy | €85.00 | $92.80 | -8.41% | 21 | Jul 14, 2025 | |
| ETR: FRE Fresenius SE & Co. KGaA | Maintained: Buy | €47.00 | $36.71 | n/a | 23 | May 7, 2025 | |
| ETR: M12 M1 Kliniken AG | Maintained: Buy | €26.00 → €28.00 | $19.00 | n/a | 15 | May 6, 2025 | |
| ETR: FME Fresenius Medical Care AG | Maintained: Hold | €43.00 | $37.24 | n/a | 20 | Feb 25, 2025 | |
| ETR: BNN BRAIN Biotech AG | Maintained: Buy | €12.80 → €5.90 | $2.97 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €5.60 | $3.92 | n/a | 1 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.50 → €17.90 | $0.88 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €30.00 → €33.00 | $13.60 | n/a | 10 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €41.00 → €56.00 | $1.20 | n/a | 2 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €4.20 → €3.50 | $0.013 | n/a | 3 | May 5, 2022 |
Evotec SE
Apr 13, 2026
Maintained: Buy
Price Target: €9.70
Current: $5.11
Upside: +89.82%
Gerresheimer AG
Feb 16, 2026
Maintained: Hold
Price Target: €30.00 → €20.00
Current: $27.90
Upside: -28.32%
SCHOTT Pharma AG & Co. KGaA
Feb 12, 2026
Maintained: Buy
Price Target: €22.00
Current: $16.90
Upside: +30.18%
Dermapharm Holding SE
Aug 26, 2025
Maintained: Hold
Price Target: €41.00
Current: $49.10
Upside: -16.50%
Formycon AG
Aug 13, 2025
Maintained: Buy
Price Target: €40.00
Current: $21.30
Upside: +87.79%
Drägerwerk AG & Co. KGaA
Jul 14, 2025
Maintained: Buy
Price Target: €85.00
Current: $92.80
Upside: -8.41%
Fresenius SE & Co. KGaA
May 7, 2025
Maintained: Buy
Price Target: €47.00
Current: $36.71
Upside: n/a
M1 Kliniken AG
May 6, 2025
Maintained: Buy
Price Target: €26.00 → €28.00
Current: $19.00
Upside: n/a
Fresenius Medical Care AG
Feb 25, 2025
Maintained: Hold
Price Target: €43.00
Current: $37.24
Upside: n/a
BRAIN Biotech AG
Nov 11, 2024
Maintained: Buy
Price Target: €12.80 → €5.90
Current: $2.97
Upside: n/a
Feb 7, 2024
Maintained: Hold
Price Target: €5.60
Current: $3.92
Upside: n/a
Dec 14, 2023
Maintained: Buy
Price Target: €16.50 → €17.90
Current: $0.88
Upside: n/a
Nov 21, 2023
Maintained: Buy
Price Target: €30.00 → €33.00
Current: $13.60
Upside: n/a
May 30, 2023
Maintained: Buy
Price Target: €41.00 → €56.00
Current: $1.20
Upside: n/a
May 5, 2022
Maintained: Buy
Price Target: €4.20 → €3.50
Current: $0.013
Upside: n/a